Chromosomal alterations in pure nonneoplastic breast lesions: Implications for breast cancer progression

Annals of Surgical Oncology

Volumn 17, Issue 6, 2010, Pages 1688-1694

  Ellsworth, Rachel E ^a   Ellsworth, Darrell L ^b   Weyandt, Jamie D ^b   Fantacone Campbell, Jamie L ^c   Brenda Deyarmin, H T ^b   Hooke, Jeffrey A ^c   Shriver, Craig D ^c  

^a Henry M Jackson Foundation for the Advancement of Military Medicine   (United States)

^b WINDBER RESEARCH INSTITUTE   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EOSIN; HEMATOXYLIN;

ADULT; ALLELIC IMBALANCE; ARTICLE; BREAST CANCER; BREAST LESION; CANCER GRADING; CANCER GROWTH; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME ABERRATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LASER MICRODISSECTION; MAJOR CLINICAL STUDY;

ALGORITHMS; ALLELIC IMBALANCE; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 17; DISEASE PROGRESSION; DNA; FEMALE; HUMANS; HYPERPLASIA; PRECANCEROUS CONDITIONS; RISK; STATISTICS, NONPARAMETRIC;

EID: 77954819026     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-0910-x     Document Type: Article

References (45)

1. MedTech Insight. MedTech Insight Report: U.S. breast disease detection and diagnostic technologies. A400. 2002. Newport Beach, CA. Ref Type: Report.
2. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975;55:231-233
3. Fraser JL, Raza S, Chorny K, Connolly JL, Schnitt SJ. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol. 1998;22:1521-1527
4. Pinder SE, Ellis IO. The diagnosis and management of preinvasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)-current definitions and classification. Breast Cancer Res. 2003;5:254-257
5. Schnitt SJ, Vincent-Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol. 2003;10:113-124
6. Oyama T, Iijima K, Takei H, Horiguchi J, Iino Y, Nakajima T, Koerner F. Atypical cystic lobule of the breast: an early stage of low-grade ductal carcinoma in situ. Breast Cancer. 2000;7:326-331
7. Goldstein NS, O'Malley BA. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma. Am J Clin Pathol. 1997;107:561-566
8. Abdel-Fatah TMA, Powe DG, Hodi Z, Lee AHS, Reis-Filho JS, Ellis IO. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tumular carcinoma and invasive lobular carcinoma. Am J Surg Pathol. 2007;31:417-426
9. Moinfar F, Man YG, Arnold L, Bratthauer GL, Ratschchek M, Tavassoli FA. Concurrent and independent genetic alterations in stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res. 2000;60:2562-2566
10. Allred DC, Mohsin SK, Fuqua SAW. Histological and biological evolution of human premalignant breast disease. Endocrine- Related Cancer. 2001;8:47-61.
11. Anderson E, Clarke RB. Steroid receptors and cell cycle in normal mammary epithelium. J Mammary Gland Biol Neoplasia. 2004;9:3-13.
12. Conneely OM, Jericevic BM, Lydon JP. Progesterone receptors in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia. 2003;8:205-214
13. Shoker BS, Jarvis C, Clarke RB, Anderson E, Hewlett J, Davies MP, Sibson DR, Sloane JP. Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am J Pathol. 1999;155:1811-1815
14. Moinfar F, Man YG, Bratthauer GL, Ratschek M, Tavassoli FA. Genetic abnormalities in mammary ductal intraepithelial neoplasia- flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium. Cancer. 88:2000;9:2072-2081
15. Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AHS, Humphreys S, Ellis IO, Lakhani SR. Columnar cell lesions of the bresat: the missing link in breast cancer progression? Am J Surg Pathol. 2005;29:734-746
16. Amari M, Suzuki A, Monya T, Yoshinga K, Amano G, Sasano H, Ohuchi N, Satomi S, Horii A. LOH analyses of premalignant and malignant lesions of human breast: frequent LOH in 8p, 16q, and 17q in atypical ductal hyperplasia. Oncol Rep. 1999;6:1277-1280
17. Gong G, DeVries S, Chew KL, Cha I, Ljung BM, Waldman FM. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin Cancer Res. 2001;7:2410-2414
18. Lakhani SR, Collins N, Stratton MR, Sloane JP. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozyogosity on chromosomes 16q and 17p. J Clin Pathol. 1995;48:611-615
19. Larson PS, de las Morenas A, Cerda SR, Bennett SR, Cupples LA, Rosenberg CL. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors. J Pathol. 2006;209:307-316
20. O'Connell P, Pekkel V, Fuqua SAW, Osborne CK, Allred DC. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst. 1998;90:697-703.
21. Ellsworth DL, Shriver CD, Ellsworth RE, Deyarmin B, Somiari RI. Laser capture microdissection of paraffin-embedded tissues. Biotechniques. 2003;34:42-46
22. Ellsworth RE, Ellsworth DL, Lubert SM, Hooke J, Somiari RI, Shriver CD. High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:915-919
23. Osborne RJ, and Hamshere MG. A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer. Cancer Res. 2000;60:3706-3712
24. Medintz IL, Lee C-CR, Wong WW, Pirkola K, Sidransky D, Mathies RA. Loss of heterozygosity assay for molecular detection of cancer using energy-transfer primers and capillary array electrophoresis. Genome Res. 2000;10:1211-1218
25. Ellsworth RE, Ellsworth DL, Deyarmin B, Hoffman LR, Love B, Hooke JA, Shriver CD. Timing of critical genetic changes in human breast disease. Ann Surg Oncol. 2005;12:1054-1060
26. Ellsworth RE, Ellsworth DL, Love B, Patney HL, Hoffman LR, Kane JL, Hooke JA, Shriver CD. Correlation of levels and patterns of genomic instability with histological grading of DCIS. Ann Surg Oncol. 2007;14:3070-3077
27. DupontWD,Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146-151
28. Page DL, Dupont WD, Rogers LW. Breast cancer risk of lobularbased hyperplasia after biopsy: "ductal" pattern lesions. Cancer Detect Prev. 1986;9:441-448
29. Shaaban AM, Sloane JP, West CR, Moore FR, Jarvis C, Williams EM, et al. Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol. 2002;26:421-430
30. McLaren BK, Gobbi H, Schuyler PA, Olson SJ, Parl FF, Dupont WD, et al. Immunohistochemical expression of estrogen receptor in enlarged lobular units with columnar alteration in benign breast biopsies: a nested case-control study. Am J Surg Pathol. 2005;29:105-108
31. Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res. 2003;5:313-319
32. Dabbs DJ, Carter G, Fudge M, Peng Y, Swalsky P, Finklestein S. Molecular alterations in columnar cell lesions of the breast. Mod Pathol. 2006;19:344-349
33. Boecker W, Buerger H, Schmitz K, Eliis IA, van Diest PJ, Sinn HP, et al. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular -weight cytokeratin expression patterns. J Pathol. 2001;195:415-421
34. Rosenberg CL, de las Morenas A, Huang K, Cupples A, Faller DV. Detection of monoclonal microsatellite alterations in atypical breast hyperplasia. J Clin Invest. 1996;98:1095-1100
35. Castro NP, Osorio CABT, Torres C, Bastos EP, Mourao-Netto M, Soares FA, et al. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res. (2008);10:R87.
36. Iakovlev VV, Arneson NCR, Wong V, Wang C, Leung S, Iakovleva G, et al. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study. Clin Cancer Res. 2008;14: 4446-4454
37. Rakha EA, Green AR, Powe DG, Roylance R, Ellis IO. Chromosome 16 tumor-suppressor genes in breast cancer. Genes Chromosomes Cancer. 2006;45:527-535
38. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al., National Surgical Adjuvant Breast and Bowel Project Investigators. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371-1388
39. Fisher B, Dignam J, Wolmark N, Wickerham DL, Fisher ER, Mamounas E, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B- 24 randomised controlled trial. Lancet. 1999;353:1993-2000. (Pubitemid 29271743)
40. Schnitt SJ. The diagnosis and management of pre-invasive breast disease: flat epithelial atypia- classification, pathologic features and clinical significance. Breast Cancer Res. 2003;5:263-268
41. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Cancer. 1953;6:963-968
42. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003;63:1727-1730
43. Levens D. Disentangling the MYC web. Proc Natl Acad Sci U S A. 2002;99:5757-5759
44. Brouillet JP, Theillet C, Maudelonde T, Defrenne A, Simony- Lafontaine J, Sertour J, et al. Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness. Eur J Cancer. 1990;26:437-441
45. Giambernardi TA, Grant GM, Taylor GP, Hay RJ, Maher VM, McCormick JJ, et al. Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol 1998;16:483-496